The Disputed Role of COX-2 in Myocardial Infarction, Is the Jury Still Out?
- 31 January 2002
- journal article
- editorial
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 34 (1) , 1-3
- https://doi.org/10.1006/jmcc.2001.1492
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Risk of Cardiovascular Events Associated With Selective COX-2 InhibitorsJAMA, 2001
- Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary ArteriesCirculation, 2001
- Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbitsProceedings of the National Academy of Sciences, 2000
- Inhibition of Cyclooxygenase-2 Improves Cardiac Function in Myocardial InfarctionBiochemical and Biophysical Research Communications, 2000
- Ischemia-reperfusion rapidly increases COX-2 expression in piglet cerebral arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 1999
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2Journal of Biological Chemistry, 1996
- Cloning Two Isoforms of Rat Cyclooxygenase: Differential Regulation of Their ExpressionArchives of Biochemistry and Biophysics, 1993
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992